Literature DB >> 1331641

Mechanism of action of capsaicin-like molecules on sensory neurons.

A Dray1.   

Abstract

Capsaicin produces pain by selectively activating polymodal nociceptive neurons. This involves a membrane depolarization and the opening of a unique, cation-selective, ion channel which can be blocked by ruthenium red. The capsaicin-induced activation is mediated by a specific membrane receptor which can be selectively and competitively antagonised by capsazepine. Repetitive administrations of capsaicin produces a desensitization and an inactivation of sensory neurons. Several mechanisms are involved. These include receptor inactivation, block of voltage activated calcium channels, intracellular accumulation of ions leading to osmotic changes and activation of proteolytic enzyme processes. Systemic and topical capsaicin produces a reversible antinociceptive and antiinflammatory action after an initial undesirable algesic effect. Capsaicin analogues, such as olvanil, have similar properties with minimal initial pungency. Systemic capsaicin produces antinociception by activating capsaicin receptors on afferent nerve terminals in the spinal cord. Spinal neurotransmission is subsequently blocked by a prolonged inactivation of sensory neurotransmitter release. Local or topical application of capsaicin blocks C-fibre conduction and inactivates neuropeptide release from peripheral nerve endings. These mechanisms account for localized antinociception and the reduction of neurogenic inflammation respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331641     DOI: 10.1016/0024-3205(92)90045-q

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  Different effects of capsaicin on I(A) and I(K) in pain-conduct neurons of rats.

Authors:  Hui Fu; Hui Liu; Xuehong Cao; Yan Hu; Jizhou Xiang; Lieju Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 2.  Dermatological and immunological conditions due to nerve lesions.

Authors:  D Bove; A Lupoli; S Caccavale; V Piccolo; E Ruocco
Journal:  Funct Neurol       Date:  2013 Apr-May

3.  Effects of ruthenium red and capsazepine on C-fibres in the rabbit iris.

Authors:  Z Y Wang; R Håkanson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

4.  Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin.

Authors:  B Joe; U J Rao; B R Lokesh
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

5.  Innervation of enteric mast cells by primary spinal afferents in guinea pig and human small intestine.

Authors:  Guo-Du Wang; Xi-Yu Wang; Sumei Liu; Meihua Qu; Yun Xia; Bradley J Needleman; Dean J Mikami; Jackie D Wood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-21       Impact factor: 4.052

6.  Dietary n-3 fatty acids, curcumin and capsaicin lower the release of lysosomal enzymes and eicosanoids in rat peritoneal macrophages.

Authors:  B Joe; B R Lokesh
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

Review 7.  Novel strategies for the treatment of inflammatory hyperalgesia.

Authors:  Atul R Chopade; Wahid A Mulla
Journal:  Eur J Clin Pharmacol       Date:  2010-02-13       Impact factor: 2.953

8.  Contrasting effects of circulating nitric oxide and nitrergic transmission on exocrine pancreatic secretion in rats.

Authors:  E Vaquero; X Molero; V Puig-Diví; J R Malagelada
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

Review 9.  Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis.

Authors:  C Rains; H M Bryson
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

10.  Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation.

Authors:  S Akerman; H Kaube; P J Goadsby
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.